Krystal Biotech, Inc. (KRYS)
299.28
-4.95
(-1.63%)
USD |
NASDAQ |
May 22, 16:00
299.00
-0.28
(-0.09%)
After-Hours: 20:00
Krystal Biotech EPS Diluted (Quarterly) : 1.833 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Scholar Rock Holding Corp. | -0.829 |
| TG Therapeutics, Inc. | 0.1236 |
| Stoke Therapeutics, Inc. | -0.7929 |
| Moderna, Inc. | -3.40 |
| Marker Therapeutics, Inc. | -0.1646 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 55.93M |
| Revenue (Quarterly) | 116.36M |
| Total Expenses (Quarterly) | 60.42M |
| Enterprise Value | 8.154B |
| Gross Profit Margin (Quarterly) | 93.26% |
| Profit Margin (Quarterly) | 48.07% |
| Earnings Yield | 2.50% |
| Operating Earnings Yield | 1.98% |
| Normalized Earnings Yield | 2.500 |